echoloc

ITF Therapeutics LLC Tech Stack

Rare disease drug development and commercialization for the US market

Pharmaceutical Manufacturing Concord, MA 51–200 employees Founded 2024 Privately Held

ITF Therapeutics is the newly launched US rare disease division of Italfarmaco, a 1938-founded global pharma company. The organization is in active hiring mode (12 roles posted in the last 30 days, velocity accelerating) with a distinctly commercial lean: healthcare, marketing, and data roles dominate the department mix, anchored by senior and director-level hires. This staffing pattern and project list—speaker bureaus, advisory boards, market research, customer segmentation—indicate a go-to-market operation still in build phase, paired with core infrastructure (SQL, Python, Tableau, SAS, Salesforce, IQVIA) typical of mid-sized pharma operations.

Tech Stack 11 technologies

Core StackPython Tableau Power BI Salesforce SAS SQL Veeva IQVIA Teams AWS EMR R

What ITF Therapeutics LLC Is Building

Challenges

  • Vendor oversight
  • Post-marketing report reconciliation
  • Timely ae report transmission
  • Optimizing marketing team performance
  • Small patient populations
  • Scouting for rare-disease partnerships
  • Understanding competitive landscape
  • Identifying market opportunities
  • Managing brand risks
  • Ensuring compliance with promotional program

Active Projects

  • Key initiatives in support of itfs greater marketing strategy
  • Pv awareness training coordination
  • Ci workshops and medical conference planning
  • Speaker bureau programs
  • Cross functional planning for key congresses
  • Market research project
  • Customer segmentation and profiling
  • Field material development
  • Advisory board planning
  • Educational presentation development

Hiring Activity

Accelerating25 roles · 10 in 30d

Department

Healthcare
6
Marketing
6
Data
4
Sales
2
Legal
1
Operations
1
Quality
1

Seniority

Senior
11
Director
9
Manager
1

Notable leadership hires: Business Development Director

Company intelligence

Find more companies like ITF Therapeutics LLC by tech stack, pain points and active projects

Get started free

About ITF Therapeutics LLC

ITF Therapeutics was established in January 2024 as Italfarmaco's dedicated US rare disease division. The company focuses on developing and commercializing treatments for rare diseases, with particular expertise signaled in Duchenne muscular dystrophy. Operating from Concord, Massachusetts, with 51–200 employees, the organization brings together clinical development, clinical research, and commercial capabilities to advance products addressing unmet needs in rare disease communities. The team actively engages with patient advocacy groups and treatment leaders to inform program design and ensure alignment with patient and clinical community priorities.

HeadquartersConcord, MA
Company Size51–200 employees
Founded2024
Hiring MarketsUnited States

Frequently Asked Questions

What is ITF Therapeutics working on?

Market research, customer segmentation, speaker bureau programs, advisory board planning, and clinical conference coordination focused on rare diseases. Projects center on go-to-market strategy, awareness training, and field material development.

What tech stack does ITF Therapeutics use?

SQL, Python, Tableau, Power BI, Veeva, Salesforce, IQVIA, SAS, and R. AWS EMR is used for data processing. No major tech migrations or adoptions are currently underway.

Similar Companies in Pharmaceutical Manufacturing

Other companies in the same industry, closest in size